Deletion of CD69 leads to alterations in the disease activity in arthritis and colitis mouse models [52–55], supporting a functional role of CD69-signaling in the regulation of Th17 differentiation and production of cytokines [56, 57], although the reports regarding the question whether CD69 deletion is clinically beneficial in these disease contexts are contradictory. Here, CD69 is linked to colitis.